More than 1000 patients have been recruited by Panthera Biopartners the UK’s largest SMO (Site Management Organisation) who recruit patients and runs clinical trials for the pharmaceutical industry. More than a 100,000 patients came forward to take part in the trials but this boiled down to just over a 1000 who met the conditions of …
Panthera’s York clinical trial site has got off to an excellent start since it was opened by the Lord Mayor of York, Councillor Margaret Wells, on 25th July last year. Not only has the site engaged with nearly 1000 local patients who want to take part in clinical trials but it has also been ranked as one …
I’m excited to share that I am stepping into the role of Chief Information Officer (CIO) at Panthera—an exciting new chapter for both me and the organisation. Over the past few years, I’ve been deeply involved in steering Panthera’s technology transformation as IT Director. Now, as CIO, I’m proud to see how far we’ve come …
Panthera Biopartners has again broadened the range of therapy areas it can run clinical trials in to include not only vaccines, cardiovascular, general medicine, diabetes, neurology, respiratory, dermatology and rheumatology but also specialist areas such as oncology, NASH and early dementia trials. The ability to carry out trials with specialist PIs (principal investigators) will attract …
Parexel has confirmed that Panthera Biopartners has become the first UK public or commercial clinical trial organisation to become part of the Parexel Site Alliance Vaccine Network. Parexel’s Site Alliance Vaccine Network is a global network of high performing clinical trial sites which fosters long-term collaborative relationships with select research organizations across the globe to …
Since announcing that it reopened its oncology clinical trials division earlier this year, Panthera Biopartners has been selected by two of the world’s largest pharma companies to run oncology trials at sites across the UK. Panthera previously had to close its Oncology division as the sites were located inside the four Rutherford Specialist Cancer clinics, …
Panthera’s SMO model delivers market-leading patient recruitment for vaccine trials In the post-COVID-19 period, the UK has emerged as a world leader in vaccine trials, but data from two case studies shows that Panthera is not only outperforming global sites, but also competitor sites across the UK. In a recent COVID-19 booster healthy volunteer vaccine trial, Panthera’s …
The UK’s largest Site Management Organisation (SMO), Panthera Biopartners, has opened the first dedicated clinical research site in York. The site, which has been operating since May, was officially opened by the Lord Mayor of York, Councillor Margaret Wells, at an opening ceremony on 25th July 2024. The clinic is located in the Acomb Garth …
Click here to read more: https://lnkd.in/erHjBc6k Includes:* Panthera remains top recruiter of patients in the UK* Panthera delivers outstanding patient recruitment for cardiovascular trials* Panthera launches new clinical research clinic in York* International Clinical Trials interview – Private vs public vaccine studies, how SMOs can secure the future of UK clinical trials* Martyn Jellett appointed as …
Independent clinical trial SMO (Site Management Organisation) Panthera Biopartners has appointed Martyn Jellett as Associate Director Business Development to support its expanding commercial team as the company continues to prosper and expand. Martyn has over 25 years experience in professional sales and business development and has extensive knowledge of the pharmaceutical and medical industry. Panthera, …
